Close
Nordic 9Nordic 9

Hemex (investor - Others)

Switzerland hemex.eu
See something wrong or missing? Let us know
Offices:Liestal

Hemex invests and supports start-ups and established biotech and medical device companies

Average round investment:6.26M USD
Average number per year:1.6
Distribution: 2025 (1)2024 (1)2022 (4)2020 (1)2019 (1)
Portfolio companies: Switzerland AnnaidaSwitzerland Hemotune AGSwitzerland Bottneuro See the entire list
Mostly invests in: Switzerland Switzerland (7) Health services (7)
See the entire list

Showing 3 of 8 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Hemex mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Hemex

Name Criteria
United States Zacua Ventures
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Software Services, Manufacturing, AI (big data)
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Switzerland Capital Risque Fribourg SA
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Biotech, Software Services, Manufacturing, AI (big data)
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Switzerland 4FO ventures
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Biotech, Software Services, Manufacturing, AI (big data)
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United Kingdom Breed Reply
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Software Services, Manufacturing, AI (big data), Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United States Dolby Family Ventures
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Biotech, Software Services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Denmark T&W Holding
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Software Services, Manufacturing, AI (big data), Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Norway Aeternum Capital
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Software Services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Switzerland Swiss Diabetes Venture Fund
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Software Services, Manufacturing, AI (big data)
  • Similar business models: B2B
  • Common investees countries: Switzerland, Sweden
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Brazil Mandi Ventures
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Cybernetix Ventures
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Biotech, Software Services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Top